VUMC News and Communications

August 11, 2022

Cell-free breast cancer “biopsy”

The circulating DNA that tumors release is a reliable metric of tumor genomics and can be used to monitor molecular changes in metastatic breast cancer.

By Sarah E. Glass
August 11, 2022

National XLH Day

Vanderbilt recently hosted the National XLH (X-linked hypophosphatemia) Day, and more than 200 patients and families attended.

By VUMC News and Communications
August 9, 2022

Inaugural Work Perks program coming Sept. 5

By VUMC News and Communications
August 5, 2022

eStar updates and changes: Easier access to prescription drug monitoring programs

By VUMC News and Communications
August 5, 2022

VUMC in the news, Aug. 9, 2022

August 5, 2022

SHARE Center presentation on addressing workplace sexual harassment at VUMC is Aug. 17

By VUMC News and Communications
August 4, 2022

Distinguished visitor

Rahul Gupta, MD, MPH, MBA, director of National Drug Control Policy visited Vanderbilt last week to learn about the Medical Center’s efforts related to child-maternal addiction care, the Firefly program and Team Hope.
By VUMC News and Communications
August 3, 2022

July MyWorkday Change Network meeting draws large crowd, addresses additional HR topics

By VUMC News and Communications
August 2, 2022

Pause in Kanban rollout for Tecsys project

By VUMC News and Communications
August 2, 2022

eStar updates and changes

By VUMC News and Communications
July 29, 2022

VUMC aligns with national 988 suicide prevention number

By VUMC News and Communications
July 28, 2022

Specialty pharmacists help reduce MS relapse risk

Just one-third of patients with relapsing multiple sclerosis remain on disease-modifying therapy, and specialty pharmacists are in a unique position to help coordinate therapy discontinuation or change and reduce the risk of relapse.
By Joshua Baker